Drug for rare muscular dystrophy fast-tracked Israeli company BioBlast targets orphan diseases that traditional pharmaceutical companies won’t touch.
SteadyMed Therapeutics joins NASDAQ The Israeli specialty pharmaceutical company is focused on using its PatchPump drug delivery system to administer medicines for orphan diseases.